- Home
- AFCG vs ANIX Comparison
AFCG vs ANIX Comparison
Compare AFCG & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AFCG
- ANIX
- Stock Information
- Founded
- AFCG 2020
- ANIX 1982
- Country
- AFCG United States
- ANIX United States
- Employees
- AFCG N/A
- ANIX N/A
- Industry
- AFCG Real Estate Investment Trusts
- ANIX Biotechnology: Pharmaceutical Preparations
- Sector
- AFCG Real Estate
- ANIX Health Care
- Exchange
- AFCG Nasdaq
- ANIX Nasdaq
- Market Cap
- AFCG 92.9M
- ANIX 95.7M
- IPO Year
- AFCG 2021
- ANIX 1987
- Fundamental
- Price
- AFCG $3.25
- ANIX $4.13
- Analyst Decision
- AFCG Hold
- ANIX Strong Buy
- Analyst Count
- AFCG 4
- ANIX 3
- Target Price
- AFCG $5.75
- ANIX $9.00
- AVG Volume (30 Days)
- AFCG 178.9K
- ANIX 302.8K
- Earning Date
- AFCG 11-12-2025
- ANIX 09-10-2025
- Dividend Yield
- AFCG 18.46%
- ANIX N/A
- EPS Growth
- AFCG N/A
- ANIX N/A
- EPS
- AFCG N/A
- ANIX N/A
- Revenue
- AFCG $8,721,514.00
- ANIX N/A
- Revenue This Year
- AFCG N/A
- ANIX N/A
- Revenue Next Year
- AFCG $13.92
- ANIX N/A
- P/E Ratio
- AFCG N/A
- ANIX N/A
- Revenue Growth
- AFCG N/A
- ANIX N/A
- 52 Week Low
- AFCG $3.10
- ANIX $2.07
- 52 Week High
- AFCG $10.20
- ANIX $4.98
- Technical
- Relative Strength Index (RSI)
- AFCG 32.27
- ANIX 53.75
- Support Level
- AFCG $3.35
- ANIX $4.00
- Resistance Level
- AFCG $3.49
- ANIX $4.44
- Average True Range (ATR)
- AFCG 0.16
- ANIX 0.25
- MACD
- AFCG 0.00
- ANIX -0.05
- Stochastic Oscillator
- AFCG 22.39
- ANIX 25.00
About AFCG AFC Gamma Inc.
Advanced Flower Capital Inc is a commercial mortgage REIT that provides institutional loans to cannabis operators in the U.S. Through the management team's deep network and related credit and cannabis expertise. The company originates, structures, and underwrites loans secured by quality real estate assets, license value, and cash flows.
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.